Developer docs
API playgroundTry for free, no card

Search company profiles

Rajiv Gandhi Centre for Biotechnology

Full company profile

uuid002cttr

Namestring
Rajiv Gandhi Centre for Biotechnology
Legal namestring
Rajiv Gandhi Centre for Biotechnology
Websiteurl
rgcb.res.in
Company typeenum
Private
Founded yearint
1990
Descriptiontext

Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is an autonomous research institute under the Department of Biotechnology, Government of India, operating from three campuses in Thiruvananthapuram, Kerala. The institute conducts frontier biotechnology research across nine programs including Cancer Research, Cardiovascular Disease and Diabetes Biology, Pathogen Biology, Regenerative Biology, Plant Biotechnology and Disease Biology, Neurobiology, Transdisciplinary Biology, and Social Interventions, while delivering translational services in clinical diagnostics, DNA forensics, and academic training. Its technical infrastructure spans a state-of-the-art DBT-SAHAJ National Facility for Mass Spectrometry (Orbitrap Eclipse Tribrid MS, Synapt XS HDMS Q-TOF, MALDI-TOF/TOF), a certified Biosafety Level-3 containment laboratory, advanced bio-imaging (Olympus FV3000, Leica SP8 WLL, Nikon A1R MP multiphoton, IVIS Spectrum), transmission electron microscopy (Thermo Talos F200i), and Sanger and next-generation sequencing platforms.

RGCB serves four primary customer categories: patients and healthcare providers through its Laboratory Medicine and Molecular Diagnostics (LMMD, ICMR VRDL Grade 1) and Medical Laboratory Services (10 main centers plus 62 collection points at CGHS rates); law enforcement and judicial agencies through its ISO/IEC 17025:2017-accredited Molecular Forensics and DNA Technologies unit; scientific researchers nationwide through fee-based access to core facilities; and students through PhD, MSc, and short-term training programs. The institute's unique regulatory position as the only DST-affiliated laboratory in India holding NABL ISO 15189-2012, NABH, and ILAC accreditations enables internationally accepted diagnostic reports.

Revenue mechanics are predominantly government-funded via DBT/BRIC annual allocations, supplemented by professional service fees from diagnostics (CGHS-rate pricing with BPL concessions), forensic DNA services (₹9,800-₹35,000 per case), core facility access (₹980-₹12,000/hour), and training programs (₹3,776-₹60,000). The institute operates a KRIBS-BIONEST bioincubator supporting biotechnology startups, participates in national consortia including INSACOG and the WHO Antibiotic Resistance Surveillance Group, and maintains memberships with the National One Health Mission's BSL-3/4 laboratory network, positioning it as a critical node within India's public health and biotechnology infrastructure.

Short descriptiontext

Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is a DBT/Government of India autonomous research institute in Thiruvananthapuram, Kerala, conducting biotechnology research across nine disease areas and delivering accredited clinical diagnostics, DNA forensics, core facility services, and graduate training programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersThiruvananthapuram, India
HQ citystring
Thiruvananthapuram
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotechnology research, molecular diagnostics, DNA forensics services, biomedical training programs, clinical laboratory services
Industry2 codes
1Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryYes
2Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Biotechnology Research Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Medical Laboratory Services
TypeProfessional Services
Description

Clinical laboratory testing services providing hematological, microbiological, immunological, and biochemical investigations. RGCB MLS operates 10 main centers and 62 collection/report centers across Thiruvananthapuram district. All investigations are priced at CGHS-approved rates with concessions for BPL patients. Revenue generated from diagnostic testing services provided to patients, government hospitals, and empaneled private facilities under CGHS.

rgcb.res.in
2Laboratory Medicine and Molecular Diagnostics
TypeProfessional Services
Description

Advanced molecular diagnostic services including 69+ viral disease tests, bacterial infection testing with genetic analysis for antibiotic resistance, next-generation sequencing for cancer and cardiovascular disease, and pharmacogenomic analysis. Revenue generated from high-complexity diagnostic testing services.

rgcb.res.in
3Molecular Forensics & DNA Technologies
TypeProfessional Services
Description

DNA fingerprinting and forensics services for judicial, crime investigation, and law enforcement agencies. Services include paternity testing (₹35,000 for 3 samples), forensic samples (₹16,800/sample), wildlife forensics species identification (₹9,800/sample), and DNA barcoding/sequencing. Commercial and non-commercial pricing tiers applied.

rgcb.res.in
4Research Consultancy Services & Molecular Platforms
TypeProfessional Services
Description

Pre-clinical testing of novel molecules for therapeutic efficacy using standardized in vitro and in vivo assays. Services include lifetime imaging, cellular imaging, and molecular screening. Charged at competitive not-for-profit service rates to support the scientific community.

rgcb.res.in
5Training and Education Programs
TypeProfessional Services
Description

Graduate school programs (PhD, MSc Biotechnology), postdoctoral training, and short/long-term skill development training programs in bioinformatics, biotech instrumentation, medical lab services, molecular diagnostics, molecular forensics, and mass spectrometry. Training fees range from ₹3,776 to ₹60,000 depending on program duration and type.

rgcb.res.in
6Core Facility Services
TypeProfessional Services
Description

Chargeable access to shared research infrastructure including genomics sequencing, mass spectrometry, bio-imaging, flow cytometry, electron microscopy, and BSL-3 facility. Services priced for academia, industry, and overseas clients with differential pricing.

rgcb.res.in
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain
Pricing details17 tiers
1Short and Long Term Training Programs
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

1 Month: ₹15,000; 2-3 Months: ₹25,000; 4-6 Months: ₹35,000; 7-12 Months: ₹60,000

rgcb.res.in
2Biotech Instrumentation Training
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

10 Days: ₹5,000; 15 Days: ₹15,000; 1 Month: ₹30,000; 3 Months: ₹45,000

rgcb.res.in
3Biotechnology Skill Development Program
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

6 Months: ₹60,000

rgcb.res.in
4Certificate Program in Bioinformatics
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

6 Months: ₹35,000 (Academia), ₹60,000 (Non-Academia), $100 (Foreign)

rgcb.res.in
5Computational Biology & Bioinformatics Training
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

1 Month: ₹15,000

rgcb.res.in
6Human DNA Fingerprinting and Identification
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

3 Weeks: ₹40,000

rgcb.res.in
7DNA Barcoding Techniques & Analysis
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

3 Weeks: ₹20,000

rgcb.res.in
8DNA Fingerprinting (RAPD/ISSR)
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

2 Weeks: ₹12,000

rgcb.res.in
9DNA Fingerprinting (Microsatellite)
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

1 Week: ₹8,000

rgcb.res.in
10Bioinformatics Analysis of DNA Sequence Data
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

1 Week: ₹10,000 (₹3,776 for non-academia)

rgcb.res.in
11Paternity Testing - Non-Commercial
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Paternity Testing (3 Samples): ₹35,000; Each additional sample: ₹9,800. Includes 18% service tax.

rgcb.res.in
12Forensic DNA Services
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Forensic Samples: ₹16,800/sample; Wildlife Species Identification: ₹9,800/sample

rgcb.res.in
13DNA Barcoding/Sequencing - Non-Commercial
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

DNA Barcoding/Sequencing: ₹2,100/sample (Non-Commercial), ₹3,150/sample (Commercial). RAPD/ISSR Fingerprinting: ₹980/sample (Non-Commercial), ₹1,540/sample (Commercial). Microsatellite Fingerprinting: ₹1,400/sample (Non-Commercial), ₹2,100/sample (Commercial). All prices include 18% service tax.

rgcb.res.in
14Health and Wellness Package
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Health Checkup (includes FBS, HbA1C, lipid profile, LFT, RFT, CBC, urine analysis, calcium, phosphorus, iron, TFT, vitamin D): ₹1,900

rgcb.res.in
15Diabetic Maintenance Panel
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Diabetic Maintenance Panel-1: ₹600; Panel-2: ₹500; Panel-3: ₹450

rgcb.res.in
16Tumor Markers
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

CA 125: ₹450; CA 72-4: ₹580; CEA: ₹300; AFP: ₹290; CA 19-9: ₹610; PSA: ₹290; Beta HCG: ₹290

rgcb.res.in
17DBT-SAHAJ Lifetime Imaging Facility Charges
ModelUnit PricingBilling cadencePay-as-you-go
Notes

White light spectral imaging: ₹3,000/hour (Academia), ₹5,000/hour (Industry); FRET acceptor bleaching/FRAP: ₹4,000/hour (Academia), ₹8,000/hour (Industry); Live cell spectral imaging: ₹3,000/hour (Academia), ₹6,000/hour (Industry); Lifetime imaging using WLL: ₹6,000/hour (Academia), ₹12,000/hour (Industry); Training on WLL spectral imaging: ₹50,000/month; Real-time spinning disc: ₹4,000/hour (Academia), ₹8,000/hour (Industry)

rgcb.res.in
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BRIC-RGCB operates as a government autonomous research institute offering a portfolio of biotechnology services: clinical molecular diagnostics (LMMD handling 220+ tests), NABH-accredited medical laboratory services via hospital-embedded units and 62 collection centers, ISO/IEC 17025:2017 accredited DNA forensics, shared access to advanced core facilities (genomics, mass spectrometry, bio-imaging, BSL-3, TEM), PhD and MSc academic programs, training and internship programs, and research consultancy. Services are delivered across three campuses in Thiruvananthapuram to government agencies, hospitals, courts, researchers, students, and individual patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • LMMD handles 220+ infectious and non-infectious disease diagnostics as one of 6 ICMR Grade 1 VRDL laboratories in India
+4 more records
Product overview1 text field

BRIC-Rajiv Gandhi Centre for Biotechnology is an autonomous institute under the Department of Biotechnology, Government of India, operating as a biotechnology research and innovation council. The institution offers a comprehensive portfolio of core research facilities and services including Laboratory Medicine and Molecular Diagnostics (handling 220+ disease diagnostics with NABL/NABH/ILAC accreditation), Medical Laboratory Services (NABH-accredited clinical labs across multiple collection centers), Molecular Forensics and DNA Technologies (ISO 17025:2017 accredited DNA fingerprinting for judicial and wildlife forensics), Genomics Facility (Sanger sequencing with AI-enabled bioinformatics), Bio-imaging Facility (advanced microscopy including TEM, confocal, multiphoton, and high-content imaging), DBT-SAHAJ Mass Spectrometry Facility (proteomics, metabolomics, lipidomics), BSL-3 Containment Laboratory (for high-risk pathogen research), Research Consultancy Services, and an accredited Central Library. Academic offerings include PhD and MSc programs across eight research disciplines. The institute also provides training programs and health checkup packages through its service centers.

Product and service14 records
1Laboratory Medicine and Molecular Diagnostics (LMMD)
CategoryCore Service
Description

ICMR Viral Research and Diagnostic Laboratory (VRDL) Grade 1 facility handling over 220 infectious and non-infectious disease diagnostics. The only lab in India under DST with NABL ISO 15189-2012, NABH, and ILAC accreditations. Offers viral disease tests, bacterial infection testing with genetic analysis for antibiotic resistance, next-generation sequencing for cancer and cardiovascular diseases, and pharmacogenomic analysis. Designed for healthcare providers, hospitals, and patients requiring globally accepted accredited reports.

2Medical Laboratory Services (MLS)
CategoryCore Service
Description

NABH-accredited clinical laboratory providing hematological, microbiological, immunological, and biochemical investigations on automated platforms at CGHS-approved rates. Operates 10 main centers and 62 collection/report centers across Thiruvananthapuram district. Services patients, government hospitals, and empaneled private facilities under CGHS. Includes BPL patient concessions.

3Molecular Forensics and DNA Technologies (MFDT) / Regional Facility for DNA Fingerprinting (RFDF)
CategoryCore Service
Description

ISO/IEC 17025:2017 accredited facility providing human DNA fingerprinting services for judicial and law enforcement agencies. Services include paternity testing, forensic analysis, rape case investigation, missing persons identification, wildlife forensics species identification, DNA barcoding of plants, animals, and microbes, and genetic diversity analysis. Differential commercial and non-commercial pricing tiers applied.

4Genomics Facility
CategoryCore Research Facility
Description

Sanger DNA sequencing facility using 3730xl DNA Analyzers (48 and 96-capillary systems) providing high-precision DNA sequencing and genotyping solutions for academia, clinics, and industry. Supports fragment analysis genotyping and offers AI-enabled bioinformatics analysis. Processes up to 96 samples in a two-hour run with up to 12 plates daily, with read lengths up to 800 bp routine and up to 1400 bp with optimized protocols.

5Transmission Electron Microscope (TEM) Facility
CategoryCore Research Facility
Description

Thermo Scientific Talos F200i S equipped with 20-200kV accelerating voltage and 4k x 4k ceta 16M camera, supporting basic TEM imaging, STEM, CRYO-EM, and tomography applications. Available to researchers across India at differential pricing for academia, industry, and overseas clients.

6Bio-imaging Facility
CategoryCore Research Facility
Description

Advanced imaging facility featuring IVIS Spectrum in vivo small animal imager, high-speed flow cytometer sorters (FACSAria III, Beckman Coulter Astrios EQ), confocal laser scanning microscopes (Olympus FV3000, Leica SP8 WLL), multiphoton confocal imaging (Nikon A1R MP), and high content imaging system (ImageXpress Confocal HT.AI). Supports flow cytometry, confocal microscopy, multiphoton imaging, and high-content screening applications.

7DBT-SAHAJ National Facility for Mass Spectrometry
CategoryCore Research Facility
Description

National facility offering proteomics, metabolomics, and lipidomics platforms with instrumentation including UltraFlextreme MALDI-TOF/TOF (Bruker), Synapt XS HDMS Q-TOF (Waters), Orbitrap Eclipse Tribrid MS (Thermo Fisher), and TSQ Altis Plus Triple Quadrupole MS (Thermo Fisher). Targeted lipidomics panels cover 309 lipid molecules across 25 lipid classes plus 2 metabolites related to one-carbon metabolism. Differential pricing for academia, industry, and overseas clients.

8Research Consultancy Services and Molecular Platforms
CategoryCore Service
Description

Pre-clinical testing services for novel molecules including standardized in vitro and in vivo assays. Offers Lifetime Imaging Facility, Cellular Imaging Facility, and Molecular Screening Facility with consultation from expert scientists. Charged at competitive not-for-profit service rates to support the scientific community.

9Biosafety Level-3 (BSL-3) Facility
CategoryCore Research Facility
Description

RCGM, KPCB, and IBSC-certified modular BSL-3 facility for research on Risk Group-3 pathogens. Supports emerging and re-emerging viral disease studies, antiviral and vaccine development, and outbreak preparedness. Participates in the National One Health Mission (NOHM) BSL-3/4 network. Equipped with negative-pressure air handling, controlled access, pass-through autoclaves, certified biosafety cabinets, and continuous surveillance.

10Comprehensive Central Library
CategorySupport Service
Description

Depository of international books and journals on life sciences with 12-hour continuous service. Provides access to over 900 e-journals and e-books through DeLCON membership, online public access catalogue (OPAC), and electronic document delivery service.

11RGCB Graduate School - PhD Program
CategoryAcademic Program
Description

Doctoral program in biotechnology with research programs spanning Cancer Research, Cardiovascular Disease and Diabetes Biology, Pathogen Biology, Regenerative Biology, Plant Biotechnology and Disease Biology, Neurobiology, Transdisciplinary Biology, and Social Interventions. Admissions through online counselling for students from across India.

12RGCB MSc Biotechnology Program
CategoryAcademic Program
Description

Master's program in biotechnology conducted under BRIC-RGCB in collaboration with University of Kerala. Designed for postgraduate students seeking advanced training in biotechnology research and applications.

13Training and Internship Programs
CategoryTraining Service
Description

Short-term and long-term training programs covering Biotech Instrumentation, Bioinformatics, DNA Fingerprinting, Flow Cytometry, Molecular Diagnostics, and Computational Biology. Includes hands-on training on specialized facilities with tiered pricing by program duration ranging from ₹3,776 to ₹60,000. Online application portal with fee payment and faculty matching.

14Health Packages
CategoryDiagnostic Service
Description

Preventive health checkup packages including Health and Wellness Package (₹1,900 with FBS, HbA1C, lipid profile, LFT, RFT, CBC, urine analysis, calcium, phosphorus, iron, TFT, vitamin D), age-specific packages, diabetic maintenance panels, tumor markers, rheumatic profile, viral markers (PCR), coagulation profile, and special investigations. Targeted at individual patients seeking preventive diagnostics.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

KRIBS-BioNest is the bioincubation centre housed at Campus III (KINFRA Hi-Tech Park). BRIC-RGCB and its bioincubation center KRIBS-BioNest participate together in national science expos and events. BioNest supports startup companies in the biotechnology sector by providing infrastructure and mentorship.

2National One Health Mission (NOHM) - National Network of BSL-3/4 Laboratories
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RGCB BSL-3 facility is a participating centre in the National One Health Mission's program for strengthening R&D towards integrated disease control and pandemic preparedness. The initiative aims to establish a national network of BSL-3/4 laboratories for outbreak investigation and pandemic preparedness, with major agencies DBT, ICMR, DHR, DAHD, and ICAR contributing laboratories. RGCB contributes through its high-containment infrastructure and metagenomics NGS surveillance.

rgcb.res.in
3INSACOG (Indian SARS-CoV-2 Genomics Consortium)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LMMD is an active member and contributor in INSACOG, where different variants of COVID-19 virus are sequenced and analysed for variant detection and reporting. This partnership connects RGCB with DBT, ICMR, and CSIR-led national genomic surveillance efforts.

rgcb.res.in
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LMMD is a participating centre with WHO's antibiotic resistance surveillance group, contributing data and research to global antibiotic resistance monitoring efforts.

5Kerala Health Services Department
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RGCB MLS operates 62 sample collection and report centers across Primary Health Centers and Family Health Centers in TVPM district under a Government Order with Kerala Health Services. Special collection centers also operate at SCTIMST, Govt Ayurveda College, Govt Homeo Hospital, and Govt Siddha Hospital.

rgcb.res.in
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wildlife forensics services provided to Kerala Forest Department for species identification from confiscated samples to enable prosecution of offenders in poaching cases. Collaboration also includes DNA barcode database development for captive animals at Thiruvananthapuram Zoo for wildlife forensics evidence.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

RGCB MLS was selected for empanelment under CGHS Trivandrum for diagnostic services to central government employees and beneficiaries, following committees formed by Ministry of Health and Family Welfare, Government of India.

8Zoological Gardens, Department of Museum & Zoos, Thiruvananthapuram
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration to develop DNA barcode database of captive animals in Thiruvananthapuram Zoo, including endemic and threatened species of the Western Ghats and migratory birds, for use in wildlife forensics.

rgcb.res.in
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RGCB is an institute of BRIC under the Department of Biotechnology, Government of India. BRIC serves as the parent council coordinating research and innovation activities across biotechnology institutes in India.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1National Centre for Biological Sciences (NCBS)
TypeDirect peer
Description

DBT-funded biology research institute in Bangalore with doctoral programs and advanced core facilities. Closely comparable to RGCB on the academic biomedical research, training, and shared-infrastructure dimensions.

TypeBroad incumbent
Description

India's largest listed diagnostics chain with pan-India network of NABL-accredited labs and routine/specialty testing at scale. Competes with RGCB MLS in CGHS-empanelled routine diagnostics with much broader geographic reach.

TypeDirect peer
Description

Autonomous DBT institute providing DNA fingerprinting for judicial/law enforcement and molecular diagnostics for disease. Most directly comparable to RGCB on the MFDT/RFDF forensics and infectious-disease diagnostics dimensions, with similar funding structure and accreditation posture.

TypeRegional player
Description

Premier research-and-teaching institution in Thiruvananthapuram offering BS-MS/PhD programs in biological sciences with advanced instrumentation. Comparable on local life-sciences academic competition and shared talent pool.

5National Institute of Biomedical Genomics (NIBMG)
TypeDirect peer
Description

Autonomous institute under DBT focused on biomedical genomics, cancer genomics, and translational research with PhD programs. Directly comparable on genomics research mandate and DBT-affiliated institute structure.

TypeBroad incumbent
Description

Pan-India NABL/NABH-accredited diagnostic chain with extensive service menu across routine, specialty, and hospital-lab management. Comparable to RGCB on accreditation tier and diagnostics menu, with far larger geographic footprint.

7Translational Health Science and Technology Institute (THSTI)
TypeDirect peer
Description

DBT autonomous institute focused on translational and clinical research including vaccines and infectious diseases, with BSL-3 facilities. Peer on translational research, public-health mandate, and DBT-funded operational model.

TypeDirect peer
Description

Premier DBT autonomous research institute in Hyderabad running multi-disciplinary biomedical research, doctoral programs, and diagnostic services. Closest peer to RGCB in governance structure (DBT autonomous), research breadth, and academic offering.

TypeDirect peer
Description

CSIR autonomous lab performing genomics, diagnostics, and translational biology with doctoral programs. Peer to RGCB on genomics-led diagnostics, infectious-disease research, and academic training.

TypeRegional player
Description

Autonomous Institute of National Importance under the Ministry of Science & Technology based in Thiruvananthapuram, with hospital services, biomedical technology, and a sample-collection partnership with RGCB MLS. Regional peer with overlapping diagnostics and biomedical device mandate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rajiv Gandhi Centre for Biotechnology

Biotechnology Research Servicesrgcb.res.in

Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is a DBT/Government of India autonomous research institute in Thiruvananthapuram, Kerala, conducting biotechnology research across nine disease areas and delivering accredited clinical diagnostics, DNA forensics, core facility services, and graduate training programs.

What Rajiv Gandhi Centre for Biotechnology does

Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is an autonomous research institute under the Department of Biotechnology, Government of India, operating from three campuses in Thiruvananthapuram, Kerala. The institute conducts frontier biotechnology research across nine programs including Cancer Research, Cardiovascular Disease and Diabetes Biology, Pathogen Biology, Regenerative Biology, Plant Biotechnology and Disease Biology, Neurobiology, Transdisciplinary Biology, and Social Interventions, while delivering translational services in clinical diagnostics, DNA forensics, and academic training. Its technical infrastructure spans a state-of-the-art DBT-SAHAJ National Facility for Mass Spectrometry (Orbitrap Eclipse Tribrid MS, Synapt XS HDMS Q-TOF, MALDI-TOF/TOF), a certified Biosafety Level-3 containment laboratory, advanced bio-imaging (Olympus FV3000, Leica SP8 WLL, Nikon A1R MP multiphoton, IVIS Spectrum), transmission electron microscopy (Thermo Talos F200i), and Sanger and next-generation sequencing platforms.

RGCB serves four primary customer categories: patients and healthcare providers through its Laboratory Medicine and Molecular Diagnostics (LMMD, ICMR VRDL Grade 1) and Medical Laboratory Services (10 main centers plus 62 collection points at CGHS rates); law enforcement and judicial agencies through its ISO/IEC 17025:2017-accredited Molecular Forensics and DNA Technologies unit; scientific researchers nationwide through fee-based access to core facilities; and students through PhD, MSc, and short-term training programs. The institute's unique regulatory position as the only DST-affiliated laboratory in India holding NABL ISO 15189-2012, NABH, and ILAC accreditations enables internationally accepted diagnostic reports.

Revenue mechanics are predominantly government-funded via DBT/BRIC annual allocations, supplemented by professional service fees from diagnostics (CGHS-rate pricing with BPL concessions), forensic DNA services (₹9,800-₹35,000 per case), core facility access (₹980-₹12,000/hour), and training programs (₹3,776-₹60,000). The institute operates a KRIBS-BIONEST bioincubator supporting biotechnology startups, participates in national consortia including INSACOG and the WHO Antibiotic Resistance Surveillance Group, and maintains memberships with the National One Health Mission's BSL-3/4 laboratory network, positioning it as a critical node within India's public health and biotechnology infrastructure.

Rajiv Gandhi Centre for Biotechnology firmographics

Firmographics
Name
Rajiv Gandhi Centre for Biotechnology
Legal name
Rajiv Gandhi Centre for Biotechnology
Website
https://rgcb.res.in
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
101–250 employees
Short description
Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is a DBT/Government of India autonomous research institute in Thiruvananthapuram, Kerala, conducting biotechnology research across nine disease areas and delivering accredited clinical diagnostics, DNA forensics, core facility services, and graduate training programs.
Ownership category
akta.pro rank

Rajiv Gandhi Centre for Biotechnology industry classification

Industry
Product category
Biotechnology Research Services
NAICS
Medical Laboratories (621511), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
akta.pro secondary industry
Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

  • Biotechnology research
  • Molecular diagnostics
  • DNA forensics services
  • Biomedical training programs
  • Clinical laboratory services

Where Rajiv Gandhi Centre for Biotechnology is headquartered

Location

Headquarters

HQ city
Thiruvananthapuram
HQ country
India
HQ region
Asia

Offices11 records

Markets served

Rajiv Gandhi Centre for Biotechnology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain

Revenue model

  1. Medical Laboratory Services: Clinical laboratory testing services providing hematological, microbiological, immunological, and biochemical investigations. RGCB MLS operates 10 main centers and 62 collection/report centers across Thiruvananthapuram district. All investigations are priced at CGHS-approved rates with concessions for BPL patients. Revenue generated from diagnostic testing services provided to patients, government hospitals, and empaneled private facilities under CGHS.
  2. Laboratory Medicine and Molecular Diagnostics: Advanced molecular diagnostic services including 69+ viral disease tests, bacterial infection testing with genetic analysis for antibiotic resistance, next-generation sequencing for cancer and cardiovascular disease, and pharmacogenomic analysis. Revenue generated from high-complexity diagnostic testing services.
  3. Molecular Forensics & DNA Technologies: DNA fingerprinting and forensics services for judicial, crime investigation, and law enforcement agencies. Services include paternity testing (₹35,000 for 3 samples), forensic samples (₹16,800/sample), wildlife forensics species identification (₹9,800/sample), and DNA barcoding/sequencing. Commercial and non-commercial pricing tiers applied.
  4. Research Consultancy Services & Molecular Platforms: Pre-clinical testing of novel molecules for therapeutic efficacy using standardized in vitro and in vivo assays. Services include lifetime imaging, cellular imaging, and molecular screening. Charged at competitive not-for-profit service rates to support the scientific community.
  5. Training and Education Programs: Graduate school programs (PhD, MSc Biotechnology), postdoctoral training, and short/long-term skill development training programs in bioinformatics, biotech instrumentation, medical lab services, molecular diagnostics, molecular forensics, and mass spectrometry. Training fees range from ₹3,776 to ₹60,000 depending on program duration and type.
  6. Core Facility Services: Chargeable access to shared research infrastructure including genomics sequencing, mass spectrometry, bio-imaging, flow cytometry, electron microscopy, and BSL-3 facility. Services priced for academia, industry, and overseas clients with differential pricing.

Pricing tiers

ModelBillingPrice
Unit PricingOne time/ perpetual licenseShort and Long Term Training Programs
Unit PricingOne time/ perpetual licenseBiotech Instrumentation Training
Unit PricingOne time/ perpetual licenseBiotechnology Skill Development Program
Unit PricingOne time/ perpetual licenseCertificate Program in Bioinformatics
Unit PricingOne time/ perpetual licenseComputational Biology & Bioinformatics Training
Unit PricingOne time/ perpetual licenseHuman DNA Fingerprinting and Identification
Unit PricingOne time/ perpetual licenseDNA Barcoding Techniques & Analysis
Unit PricingOne time/ perpetual licenseDNA Fingerprinting (RAPD/ISSR)
Unit PricingOne time/ perpetual licenseDNA Fingerprinting (Microsatellite)
Unit PricingOne time/ perpetual licenseBioinformatics Analysis of DNA Sequence Data
Unit PricingOne time/ perpetual licensePaternity Testing - Non-Commercial
Unit PricingOne time/ perpetual licenseForensic DNA Services
Unit PricingOne time/ perpetual licenseDNA Barcoding/Sequencing - Non-Commercial
Unit PricingOne time/ perpetual licenseHealth and Wellness Package
Unit PricingOne time/ perpetual licenseDiabetic Maintenance Panel
Unit PricingOne time/ perpetual licenseTumor Markers
Unit PricingPay-as-you-goDBT-SAHAJ Lifetime Imaging Facility Charges

Go-to-market motion2 records

Distribution channels7 records

Marketing channels6 records

Rajiv Gandhi Centre for Biotechnology product offering

Product offering

Core offering

BRIC-RGCB operates as a government autonomous research institute offering a portfolio of biotechnology services: clinical molecular diagnostics (LMMD handling 220+ tests), NABH-accredited medical laboratory services via hospital-embedded units and 62 collection centers, ISO/IEC 17025:2017 accredited DNA forensics, shared access to advanced core facilities (genomics, mass spectrometry, bio-imaging, BSL-3, TEM), PhD and MSc academic programs, training and internship programs, and research consultancy. Services are delivered across three campuses in Thiruvananthapuram to government agencies, hospitals, courts, researchers, students, and individual patients.

Product overview

BRIC-Rajiv Gandhi Centre for Biotechnology is an autonomous institute under the Department of Biotechnology, Government of India, operating as a biotechnology research and innovation council. The institution offers a comprehensive portfolio of core research facilities and services including Laboratory Medicine and Molecular Diagnostics (handling 220+ disease diagnostics with NABL/NABH/ILAC accreditation), Medical Laboratory Services (NABH-accredited clinical labs across multiple collection centers), Molecular Forensics and DNA Technologies (ISO 17025:2017 accredited DNA fingerprinting for judicial and wildlife forensics), Genomics Facility (Sanger sequencing with AI-enabled bioinformatics), Bio-imaging Facility (advanced microscopy including TEM, confocal, multiphoton, and high-content imaging), DBT-SAHAJ Mass Spectrometry Facility (proteomics, metabolomics, lipidomics), BSL-3 Containment Laboratory (for high-risk pathogen research), Research Consultancy Services, and an accredited Central Library. Academic offerings include PhD and MSc programs across eight research disciplines. The institute also provides training programs and health checkup packages through its service centers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Laboratory Medicine and Molecular Diagnostics (LMMD) ICMR Viral Research and Diagnostic Laboratory (VRDL) Grade 1 facility handling over 220 infectious and non-infectious disease diagnostics. The only lab in India under DST with NABL ISO 15189-2012, NABH, and ILAC accreditations. Offers viral disease tests, bacterial infection testing with genetic analysis for antibiotic resistance, next-generation sequencing for cancer and cardiovascular diseases, and pharmacogenomic analysis. Designed for healthcare providers, hospitals, and patients requiring globally accepted accredited reports.
  • Medical Laboratory Services (MLS) NABH-accredited clinical laboratory providing hematological, microbiological, immunological, and biochemical investigations on automated platforms at CGHS-approved rates. Operates 10 main centers and 62 collection/report centers across Thiruvananthapuram district. Services patients, government hospitals, and empaneled private facilities under CGHS. Includes BPL patient concessions.
  • Molecular Forensics and DNA Technologies (MFDT) / Regional Facility for DNA Fingerprinting (RFDF) ISO/IEC 17025:2017 accredited facility providing human DNA fingerprinting services for judicial and law enforcement agencies. Services include paternity testing, forensic analysis, rape case investigation, missing persons identification, wildlife forensics species identification, DNA barcoding of plants, animals, and microbes, and genetic diversity analysis. Differential commercial and non-commercial pricing tiers applied.
  • Genomics Facility Sanger DNA sequencing facility using 3730xl DNA Analyzers (48 and 96-capillary systems) providing high-precision DNA sequencing and genotyping solutions for academia, clinics, and industry. Supports fragment analysis genotyping and offers AI-enabled bioinformatics analysis. Processes up to 96 samples in a two-hour run with up to 12 plates daily, with read lengths up to 800 bp routine and up to 1400 bp with optimized protocols.
  • Transmission Electron Microscope (TEM) Facility Thermo Scientific Talos F200i S equipped with 20-200kV accelerating voltage and 4k x 4k ceta 16M camera, supporting basic TEM imaging, STEM, CRYO-EM, and tomography applications. Available to researchers across India at differential pricing for academia, industry, and overseas clients.
  • Bio-imaging Facility Advanced imaging facility featuring IVIS Spectrum in vivo small animal imager, high-speed flow cytometer sorters (FACSAria III, Beckman Coulter Astrios EQ), confocal laser scanning microscopes (Olympus FV3000, Leica SP8 WLL), multiphoton confocal imaging (Nikon A1R MP), and high content imaging system (ImageXpress Confocal HT.AI). Supports flow cytometry, confocal microscopy, multiphoton imaging, and high-content screening applications.
  • DBT-SAHAJ National Facility for Mass Spectrometry National facility offering proteomics, metabolomics, and lipidomics platforms with instrumentation including UltraFlextreme MALDI-TOF/TOF (Bruker), Synapt XS HDMS Q-TOF (Waters), Orbitrap Eclipse Tribrid MS (Thermo Fisher), and TSQ Altis Plus Triple Quadrupole MS (Thermo Fisher). Targeted lipidomics panels cover 309 lipid molecules across 25 lipid classes plus 2 metabolites related to one-carbon metabolism. Differential pricing for academia, industry, and overseas clients.
  • Research Consultancy Services and Molecular Platforms Pre-clinical testing services for novel molecules including standardized in vitro and in vivo assays. Offers Lifetime Imaging Facility, Cellular Imaging Facility, and Molecular Screening Facility with consultation from expert scientists. Charged at competitive not-for-profit service rates to support the scientific community.
  • Biosafety Level-3 (BSL-3) Facility RCGM, KPCB, and IBSC-certified modular BSL-3 facility for research on Risk Group-3 pathogens. Supports emerging and re-emerging viral disease studies, antiviral and vaccine development, and outbreak preparedness. Participates in the National One Health Mission (NOHM) BSL-3/4 network. Equipped with negative-pressure air handling, controlled access, pass-through autoclaves, certified biosafety cabinets, and continuous surveillance.
  • Comprehensive Central Library Depository of international books and journals on life sciences with 12-hour continuous service. Provides access to over 900 e-journals and e-books through DeLCON membership, online public access catalogue (OPAC), and electronic document delivery service.
  • RGCB Graduate School - PhD Program Doctoral program in biotechnology with research programs spanning Cancer Research, Cardiovascular Disease and Diabetes Biology, Pathogen Biology, Regenerative Biology, Plant Biotechnology and Disease Biology, Neurobiology, Transdisciplinary Biology, and Social Interventions. Admissions through online counselling for students from across India.
  • RGCB MSc Biotechnology Program Master's program in biotechnology conducted under BRIC-RGCB in collaboration with University of Kerala. Designed for postgraduate students seeking advanced training in biotechnology research and applications.
  • Training and Internship Programs Short-term and long-term training programs covering Biotech Instrumentation, Bioinformatics, DNA Fingerprinting, Flow Cytometry, Molecular Diagnostics, and Computational Biology. Includes hands-on training on specialized facilities with tiered pricing by program duration ranging from ₹3,776 to ₹60,000. Online application portal with fee payment and faculty matching.
  • Health Packages Preventive health checkup packages including Health and Wellness Package (₹1,900 with FBS, HbA1C, lipid profile, LFT, RFT, CBC, urine analysis, calcium, phosphorus, iron, TFT, vitamin D), age-specific packages, diabetic maintenance panels, tumor markers, rheumatic profile, viral markers (PCR), coagulation profile, and special investigations. Targeted at individual patients seeking preventive diagnostics.

Quantifiable outcome

  • LMMD handles 220+ infectious and non-infectious disease diagnostics as one of 6 ICMR Grade 1 VRDL laboratories in India
  • +4 more outcomes

Companies that use Rajiv Gandhi Centre for Biotechnology

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Rajiv Gandhi Centre for Biotechnology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Rajiv Gandhi Centre for Biotechnology partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • KRIBS-BioNest (Bioincubation Centre)coreStrategic or Co-development PartnerKRIBS-BioNest is the bioincubation centre housed at Campus III (KINFRA Hi-Tech Park). BRIC-RGCB and its bioincubation center KRIBS-BioNest participate together in national science expos and events. BioNest supports startup companies in the biotechnology sector by providing infrastructure and mentorship.
  • National One Health Mission (NOHM) - National Network of BSL-3/4 LaboratoriescoreStrategic or Co-development PartnerRGCB BSL-3 facility is a participating centre in the National One Health Mission's program for strengthening R&D towards integrated disease control and pandemic preparedness. The initiative aims to establish a national network of BSL-3/4 laboratories for outbreak investigation and pandemic preparedness, with major agencies DBT, ICMR, DHR, DAHD, and ICAR contributing laboratories. RGCB contributes through its high-containment infrastructure and metagenomics NGS surveillance.
  • INSACOG (Indian SARS-CoV-2 Genomics Consortium)coreStrategic or Co-development PartnerLMMD is an active member and contributor in INSACOG, where different variants of COVID-19 virus are sequenced and analysed for variant detection and reporting. This partnership connects RGCB with DBT, ICMR, and CSIR-led national genomic surveillance efforts.
  • WHO Antibiotic Resistance Surveillance GroupcoreStrategic or Co-development PartnerLMMD is a participating centre with WHO's antibiotic resistance surveillance group, contributing data and research to global antibiotic resistance monitoring efforts.
  • Kerala Health Services DepartmentcoreStrategic or Co-development PartnerRGCB MLS operates 62 sample collection and report centers across Primary Health Centers and Family Health Centers in TVPM district under a Government Order with Kerala Health Services. Special collection centers also operate at SCTIMST, Govt Ayurveda College, Govt Homeo Hospital, and Govt Siddha Hospital.
  • Kerala Forest DepartmentcoreStrategic or Co-development PartnerWildlife forensics services provided to Kerala Forest Department for species identification from confiscated samples to enable prosecution of offenders in poaching cases. Collaboration also includes DNA barcode database development for captive animals at Thiruvananthapuram Zoo for wildlife forensics evidence.
  • CGHS (Central Government Health Scheme)coreStrategic or Co-development PartnerRGCB MLS was selected for empanelment under CGHS Trivandrum for diagnostic services to central government employees and beneficiaries, following committees formed by Ministry of Health and Family Welfare, Government of India.
  • Zoological Gardens, Department of Museum & Zoos, ThiruvananthapuramminorStrategic or Co-development PartnerCollaboration to develop DNA barcode database of captive animals in Thiruvananthapuram Zoo, including endemic and threatened species of the Western Ghats and migratory birds, for use in wildlife forensics.
  • BRIC (Biotechnology Research and Innovation Council)coreStrategic or Co-development PartnerRGCB is an institute of BRIC under the Department of Biotechnology, Government of India. BRIC serves as the parent council coordinating research and innovation activities across biotechnology institutes in India.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Rajiv Gandhi Centre for Biotechnology competitors and assessment

Company assessment

Direct peers

  • National Centre for Biological Sciences (NCBS): DBT-funded biology research institute in Bangalore with doctoral programs and advanced core facilities. Closely comparable to RGCB on the academic biomedical research, training, and shared-infrastructure dimensions.
  • Centre for DNA Fingerprinting and Diagnostics (CDFD): Autonomous DBT institute providing DNA fingerprinting for judicial/law enforcement and molecular diagnostics for disease. Most directly comparable to RGCB on the MFDT/RFDF forensics and infectious-disease diagnostics dimensions, with similar funding structure and accreditation posture.
  • National Institute of Biomedical Genomics (NIBMG): Autonomous institute under DBT focused on biomedical genomics, cancer genomics, and translational research with PhD programs. Directly comparable on genomics research mandate and DBT-affiliated institute structure.
  • Translational Health Science and Technology Institute (THSTI): DBT autonomous institute focused on translational and clinical research including vaccines and infectious diseases, with BSL-3 facilities. Peer on translational research, public-health mandate, and DBT-funded operational model.
  • Centre for Cellular and Molecular Biology (CCMB): Premier DBT autonomous research institute in Hyderabad running multi-disciplinary biomedical research, doctoral programs, and diagnostic services. Closest peer to RGCB in governance structure (DBT autonomous), research breadth, and academic offering.
  • Institute of Genomics and Integrative Biology (IGIB): CSIR autonomous lab performing genomics, diagnostics, and translational biology with doctoral programs. Peer to RGCB on genomics-led diagnostics, infectious-disease research, and academic training.

Broad incumbents

  • Dr. Lal PathLabs: India's largest listed diagnostics chain with pan-India network of NABL-accredited labs and routine/specialty testing at scale. Competes with RGCB MLS in CGHS-empanelled routine diagnostics with much broader geographic reach.
  • Metropolis Healthcare: Pan-India NABL/NABH-accredited diagnostic chain with extensive service menu across routine, specialty, and hospital-lab management. Comparable to RGCB on accreditation tier and diagnostics menu, with far larger geographic footprint.

Regional players

  • IISER Thiruvananthapuram: Premier research-and-teaching institution in Thiruvananthapuram offering BS-MS/PhD programs in biological sciences with advanced instrumentation. Comparable on local life-sciences academic competition and shared talent pool.
  • Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST): Autonomous Institute of National Importance under the Ministry of Science & Technology based in Thiruvananthapuram, with hospital services, biomedical technology, and a sample-collection partnership with RGCB MLS. Regional peer with overlapping diagnostics and biomedical device mandate.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Customer concentration

Rajiv Gandhi Centre for Biotechnology social profiles

Digital presence

Rajiv Gandhi Centre for Biotechnology compliance and trust

Trust signal

Compliance9 records

Rajiv Gandhi Centre for Biotechnology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rajiv Gandhi Centre for Biotechnology leadership team

Management profile

Number of profiles

Profiles16 records

Rajiv Gandhi Centre for Biotechnology subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Rajiv Gandhi Centre for Biotechnology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rajiv Gandhi Centre for Biotechnology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rajiv Gandhi Centre for Biotechnology

What does Rajiv Gandhi Centre for Biotechnology do?

BRIC-RGCB operates as a government autonomous research institute offering a portfolio of biotechnology services: clinical molecular diagnostics (LMMD handling 220+ tests), NABH-accredited medical laboratory services via hospital-embedded units and 62 collection centers, ISO/IEC 17025:2017 accredited DNA forensics, shared access to advanced core facilities (genomics, mass spectrometry, bio-imaging, BSL-3, TEM), PhD and MSc academic programs, training and internship programs, and research consultancy. Services are delivered across three campuses in Thiruvananthapuram to government agencies, hospitals, courts, researchers, students, and individual patients.

Is Rajiv Gandhi Centre for Biotechnology a public or private company?

Rajiv Gandhi Centre for Biotechnology is a private company. It is classified as state government owned and is currently operating.

When was Rajiv Gandhi Centre for Biotechnology founded?

Rajiv Gandhi Centre for Biotechnology was founded in 1990. It employs 101 to 250 people.

Where is Rajiv Gandhi Centre for Biotechnology based?

Rajiv Gandhi Centre for Biotechnology is headquartered in Thiruvananthapuram, India, in the Asia region.

How does Rajiv Gandhi Centre for Biotechnology make money?

Six revenue lines are on record. Medical Laboratory Services are the primary driver. The others are laboratory Medicine and Molecular Diagnostics, molecular Forensics & DNA Technologies, research Consultancy Services & Molecular Platforms, training and Education Programs and core Facility Services.

Who are Rajiv Gandhi Centre for Biotechnology's main competitors?

Direct peers on record are National Centre for Biological Sciences (NCBS), Centre for DNA Fingerprinting and Diagnostics (CDFD), National Institute of Biomedical Genomics (NIBMG), Translational Health Science and Technology Institute (THSTI), Centre for Cellular and Molecular Biology (CCMB) and Institute of Genomics and Integrative Biology (IGIB). Broad incumbents are Dr. Lal PathLabs and Metropolis Healthcare. Regional players are IISER Thiruvananthapuram and Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST).

Does Rajiv Gandhi Centre for Biotechnology have an API?

No public API is recorded for Rajiv Gandhi Centre for Biotechnology.

What industry is Rajiv Gandhi Centre for Biotechnology in?

Rajiv Gandhi Centre for Biotechnology's product category is Biotechnology Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Press Information BureauPress Release Page | Press Information BureauThe Rajiv Gandhi Centre for Biotechnology (RGCB) received orphan drug designation from the US FDA for Uttroside-B, a compound isolated from Manathakkali leaves with potential anti-cancer properties. The technology was subsequently acquired by the US pharmaceutical company QBioMed through a transfer facilitated by the Oklahoma Medical Research Foundation.BioTecNikaPhD in Biotechnology Admissions at BRIC-RGCB | Apply NowThe Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is inviting applications for its full-time residential PhD program in Biotechnology and related life sciences disciplines for the January 2026 session. The program requires candidates to hold a relevant postgraduate degree with a valid Junior Research Fellowship from national schemes, with applications due by November 14, 2025. Selection involves offline interviews and laboratory assessments at the institute's campus in Kerala.PR NewswireQ BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancerQ BioMed announced a new publication in Frontiers in Oncology showing that its Uttroside-B drug candidate for liver cancer is significantly more effective when combined with chloroquine, which inhibits autophagy. The research, led by Dr. Ruby John Anto at the Rajiv Gandhi Centre for Biotechnology, found that blocking autophagy enhanced Utt-B's antitumor efficacy in both cell culture and animal models of hepatocellular carcinoma. Q BioMed holds exclusive license to the technology and is finalizing manufacturing for toxicology studies ahead of potential clinical trials.PR NewswireQ Biomed Joins with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology to Develop Liver Cancer ChemotherapeuticQ BioMed Inc. announced a collaboration with the Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology to develop uttroside B, a chemotherapeutic compound derived from the Solanum nigrum Linn plant, for treating hepatocellular carcinoma. Preclinical studies published in Scientific Reports demonstrated that uttroside B was ten times more cytotoxic to liver cancer cells than the only FDA-approved drug and drastically shrunk tumors in mice without noticeable side effects. The companies intend to conduct further preclinical and clinical evaluation, with the goal of bringing an effective treatment to patients who currently have very limited therapeutic options for liver cancer.